Tag: GLOBAL FUND

#BREAKING: Ethiopia Declares Marburg Virus Outbreak

Michael Gwarisa

By Michael Gwarisa Health officials who were initially skeptical about the cause of a suspected haemorrhagic fever reported in Jinka, Southern Region of Ethiopia, have now confirmed that the disease is the Marburg virus. Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe and often fatal illness in humans. The average case fatality rate is around 50 percent, although previous outbreaks have recorded rates ranging from 24 to 88 percent. In a statement, the Africa Centres for Disease Control and Prevention (Africa CDC) said the Federal…

Read More

Funding Cuts Push Zimbabwe to Consider Reusable Circumcision Kits

Michael Gwarisa

By Michael Gwarisa Zimbabwe is exploring the use of reusable circumcision kits to sustain voluntary medical male circumcision (VMMC) services amid declining international funding and the gradual withdrawal of donor support. VMMC has been a key HIV prevention tool in Zimbabwe, credited with significantly reducing new HIV infections since the program’s launch in 2009. At its peak in 2012, the program recorded over 1.1 million circumcisions, contributing to the national goal of achieving 80% coverage among adult males and newborns. In the long term, Zimbabwe aimed to maintain around 150,000…

Read More

Zambia launches malaria vaccine to protect over half a million children

Michael Gwarisa

Lusaka – The Government of the Republic of Zambia, through the Ministry of Health, today officially launched the malaria vaccine (R21/Matrix-M) as part of its Expanded Programme on Immunization (EPI), marking a historic milestone in the country’s fight against malaria. Over 500 000 children aged 6‒8 months will be vaccinated in the months following the launch. Malaria remains one of Zambia’s leading causes of illness and death, particularly among children under five years of age. In 2023 alone, malaria incidence among this age group rose to 523 cases per 1000 population, according to the…

Read More

Global Fund Appeals for Support Ahead of 8th Replenishment, Calls for African Ownership of HIV Programs

Michael Gwarisa

By Michael Gwarisa in Durban The Global Fund last night took to the platform at the ongoing 4th CPHIA Conference in Durban, South Africa, to call for support towards the 8th Replenishment, aimed at strengthening HIV programs amid shrinking donor support. The Global Fund’s 8th Replenishment is a campaign launched in 2025 to raise 18 billion US dollars to fight HIV, TB, and malaria between 2027 and 2029. The 8th cycle aims to save 23 million lives, avert 400 million infections, reduce mortality by 64% compared to 2023, and strengthen…

Read More

Zimbabwe Steps Up Disease Surveillance at Borders Through Epidemiologist Training

Michael Gwarisa

By Michael Gwarisa Zimbabwe has strengthened its frontline disease surveillance capacity with the graduation of 44 health workers from the Zimbabwe Field Epidemiology Training Programme (ZimFETP). The three-month training targeted officers stationed at ports of entry and epidemiologists working within city health departments, equipping them with practical skills to detect, investigate, and respond swiftly to outbreaks. Of the graduates, 20 were drawn from land borders and international airports while 24 came from city health departments across the country. The training was designed to close gaps in disease detection and response…

Read More

Zimbabwe Selected Among Ten Countries to Roll Out Breakthrough HIV Prevention Drug, Lenacapavir

Michael Gwarisa

By Michael Gwarisa  Zimbabwe has been selected as one of ten countries globally to roll out lenacapavir, a revolutionary new HIV prevention drug that is being hailed as a game-changer in the global fight against HIV. The announcement was made on the official U.S. Embassy Zimbabwe Facebook page, marking a historic milestone in the country’s decades-long battle to curb new HIV infections. Lenacapavir, developed by U.S.-based Gilead Sciences in partnership with the Global Fund, is the world’s first twice-yearly HIV prevention medicine. Clinical trial data shows that more than 99%…

Read More

UNAIDS Welcomes US Move to Expand HIV Prevention Access

Michael Gwarisa

By Staff Reporter  UNAIDS welcomes the announcement by the US State Department that the President’s Emergency Plan for AIDS Relief (PEPFAR) will be supporting an initiative by the Global Fund to Fight AIDS, TB and Malaria to provide lenacapavir to up to 2 million people in countries with high burdens of HIV. Lenacapavir, an American-based innovation, is one of the most promising new HIV prevention tools that has emerged in the HIV response, offering protection against HIV with just twice-yearly injections. The breakthrough medicine will save thousands of lives if…

Read More

Two Generations, One Battle: Global Fund’s Role in Zimbabwe’s ARV Success

Michael Gwarisa

By Michael Gwarisa When Otilia Tasikasni learned she was HIV positive in 1991, she believed her life was over. The diagnosis then was not just a medical statement; it was a countdown. Doctors told her she had only two or three years to live, and every day felt like borrowed time. “At one point, all I would think of was dying,” recalls the 59-year-old, her voice steady but her eyes betraying memories of that period. “Even though I was not sick then or showing any signs of illness, I was…

Read More

UNDP Officially Hands Over Masvingo Natpharm Warehouse to Zimbabwe Government

Michael Gwarisa

By Michael Gwarisa in Masvingo Health facilities in Masvingo Province are set to benefit from a multi-million dollar Natpharm Pharmaceutical Warehouse facility constructed through a partnership between the government of Zimbabwe, the Global Fund and the United Nations Development Porgramme (UNDP). The 2,460 square meters new warehouse for NatPharm in Masvingo which holds 2,988 pallet spaces was constructed at a cost of US$ 3,667,724.51. Construction started in 2017 to be completed and handed over to NatPharm for occupation in the first quarter of 2020. Officiating the official handover ceremony of…

Read More

#Breaking: Donors About To Pull The Plug On Condom Funding In Zimbabwe

Michael Gwarisa

By Michael Gwarisa One of the major funders for HIV and AIDS programs in Zimbabwe, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), has notified the Zimbabwean government that it will terminate funding for condom programming within the next 30 months, HealthTimes has learnt. Popularly known as Madhimbare mainly because of their blue and white packaging, public sector condoms serve the biggest number of condom users in Zimbabwe especially those at high risk of HIV infection mainly Female Sex Workers (FSW), Artisanal Miners, Truck Drivers among other HIV key…

Read More